If you liked this article you might like

Biotech Movers: Sarepta, Paratek, PDL BioPharma
Takeaways and Observations; The Good, the Bad and the Ugly: Doug Kass' Views
Jim Cramer -- Eli Lilly Is the New 'Darling' of Big Pharma
Jim Cramer Says Incyte Has an Amazing Pipeline of Treatments